As far as CML is concerned, the presence of these LSC is probably the main reason of the failure of BCR/Abl-targeting TKi to eradicate LSC, suppress MRD, and prevent relapse of disease [51]. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.